Decatur Capital Management Inc. acquired a new position in shares of Chemed Co. (NYSE:CHE) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 9,600 shares of the company’s stock, valued at approximately $4,009,000. Decatur Capital Management Inc. owned approximately 0.06% of Chemed at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Municipal Employees Retirement System of Michigan increased its holdings in shares of Chemed by 1.0% during the second quarter. Municipal Employees Retirement System of Michigan now owns 2,950 shares of the company’s stock worth $1,064,000 after buying an additional 30 shares in the last quarter. Advisory Services Network LLC increased its holdings in shares of Chemed by 117.9% in the second quarter. Advisory Services Network LLC now owns 85 shares of the company’s stock valued at $30,000 after purchasing an additional 46 shares in the last quarter. Bbva USA Bancshares Inc. increased its holdings in shares of Chemed by 2.4% in the second quarter. Bbva USA Bancshares Inc. now owns 2,579 shares of the company’s stock valued at $931,000 after purchasing an additional 61 shares in the last quarter. Advisor Group Inc. increased its holdings in shares of Chemed by 2.8% in the second quarter. Advisor Group Inc. now owns 2,305 shares of the company’s stock valued at $833,000 after purchasing an additional 63 shares in the last quarter. Finally, Treasurer of the State of North Carolina increased its holdings in shares of Chemed by 1.1% in the second quarter. Treasurer of the State of North Carolina now owns 6,244 shares of the company’s stock valued at $2,253,000 after purchasing an additional 66 shares in the last quarter. 87.12% of the stock is owned by institutional investors.
CHE has been the subject of a number of research reports. ValuEngine lowered shares of Chemed from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Oppenheimer raised their price target on shares of Chemed from $400.00 to $430.00 and gave the company an “outperform” rating in a report on Thursday, August 1st. Bank of America raised their price target on shares of Chemed from $470.00 to $500.00 and gave the company a “buy” rating in a report on Friday, September 6th. Finally, Royal Bank of Canada raised their price target on shares of Chemed to $405.00 and gave the company a “sector perform” rating in a report on Monday, July 29th. One analyst has rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating to the stock. Chemed currently has an average rating of “Hold” and a consensus price target of $411.25.
In other news, Director George J. Walsh III purchased 500 shares of Chemed stock in a transaction dated Wednesday, August 7th. The shares were bought at an average cost of $412.86 per share, with a total value of $206,430.00. Following the completion of the transaction, the director now directly owns 4,520 shares in the company, valued at approximately $1,866,127.20. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Walter L. Krebs sold 2,910 shares of Chemed stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $430.41, for a total transaction of $1,252,493.10. Following the transaction, the director now directly owns 9,318 shares in the company, valued at $4,010,560.38. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 46,812 shares of company stock worth $20,005,507. Insiders own 3.96% of the company’s stock.
CHE stock traded up $6.76 during midday trading on Friday, reaching $420.27. The company’s stock had a trading volume of 1,386 shares, compared to its average volume of 116,826. Chemed Co. has a 52 week low of $260.03 and a 52 week high of $441.79. The stock has a market cap of $6.43 billion, a PE ratio of 35.14, a price-to-earnings-growth ratio of 2.75 and a beta of 1.11. The company has a quick ratio of 0.78, a current ratio of 0.81 and a debt-to-equity ratio of 0.25. The business’s 50-day simple moving average is $422.92 and its 200-day simple moving average is $371.25.
Chemed (NYSE:CHE) last announced its quarterly earnings data on Thursday, July 25th. The company reported $3.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.09 by $0.27. Chemed had a net margin of 10.94% and a return on equity of 35.63%. The firm had revenue of $473.60 million for the quarter, compared to analysts’ expectations of $471.72 million. During the same period last year, the firm earned $2.81 earnings per share. The business’s revenue for the quarter was up 7.2% on a year-over-year basis. As a group, equities analysts forecast that Chemed Co. will post 13.54 earnings per share for the current fiscal year.
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.
Featured Story: What is a closed-end mutual fund (CEF)?
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.